Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
Rudenko L, Kiseleva I, Stukova M, Erofeeva M, Naykhin A, Donina S, Larionova N, Pisareva M, Krivitskaya V, Flores J; Russian LAIV Trial Study Group. Rudenko L, et al. Among authors: donina s. Vaccine. 2015 Sep 22;33(39):5110-7. doi: 10.1016/j.vaccine.2015.08.019. Epub 2015 Aug 19. Vaccine. 2015. PMID: 26296497 Clinical Trial.
Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method.
Petukhova G, Naikhin A, Chirkova T, Donina S, Korenkov D, Rudenko L. Petukhova G, et al. Among authors: donina s. Vaccine. 2009 Apr 28;27(19):2580-7. doi: 10.1016/j.vaccine.2009.02.035. Epub 2009 Feb 20. Vaccine. 2009. PMID: 19428864
Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O. Rudenko L, et al. Among authors: donina s. PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014. PLoS One. 2014. PMID: 24533064 Free PMC article. Clinical Trial.
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.
Isakova-Sivak I, Stukova M, Erofeeva M, Naykhin A, Donina S, Petukhova G, Kuznetsova V, Kiseleva I, Smolonogina T, Dubrovina I, Pisareva M, Nikiforova A, Power M, Flores J, Rudenko L. Isakova-Sivak I, et al. Among authors: donina s. Hum Vaccin Immunother. 2015;11(4):970-82. doi: 10.1080/21645515.2015.1010859. Hum Vaccin Immunother. 2015. PMID: 25831405 Free PMC article. Clinical Trial.
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Rudenko L, Naykhin A, Donina S, Korenkov D, Petukhova G, Isakova-Sivak I, Losev I, Stukova M, Erofeeva M, Nikiforova A, Power M, Flores J. Rudenko L, et al. Among authors: donina s. Hum Vaccin Immunother. 2015;11(12):2839-48. doi: 10.1080/21645515.2015.1069931. Hum Vaccin Immunother. 2015. PMID: 26697973 Free PMC article. Clinical Trial.
57 results